Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$81.8M Buy
9,102,300
+198,000
+2% +$1.82M 0.4% 55
2026
Q1
$82.7M Buy
8,904,300
+126,800
+1% +$1.25M 0.51% 46
2025
Q4
$61.4M Sell
8,777,500
-5,283,400
-38% -$33.2M 0.37% 53
2025
Q3
$80.3M Buy
+14,060,900
New +$75M 0.43% 42
2023
Q2
Sell
-2,248
Closed -$41.6K 639
2023
Q1
$41.6K Buy
+2,248
New +$42.3K ﹤0.01% 583

Other funds holding NEOG

ING Group's NEOG Position: Q2 2026 in Review

ING Group increased its Neogen (NEOG) stake by 2.2% in Q2 2026, buying an estimated $1.82M and bringing the position to 9,102,300 shares worth $81.8M. The position accounts for 0.4% of the portfolio, ranked #55.

ING Group first reported a position in NEOG in Q1 2023 and has held it in 5 quarters since. The position peaked at $82.7M in Q1 2026. 316 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

  • ING Group held 9,102,300 shares of Neogen worth $81.8M as of Q2 2026.
  • ING Group bought 198,000 Neogen shares in Q2 2026, an estimated $1.82M.
  • Neogen made up 0.4% of ING Group's portfolio in Q2 2026, its #55 holding.
  • ING Group first reported a position in Neogen in Q1 2023 and has held it in 5 quarters since.
  • ING Group's Neogen position peaked at $82.7M in Q1 2026.
  • 316 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on ING Group's 13F filing for Q2 2026, filed 13 Aug 2026.